ATE310078T1 - Hühner-anäemie-virus mit geringer pathogenität - Google Patents

Hühner-anäemie-virus mit geringer pathogenität

Info

Publication number
ATE310078T1
ATE310078T1 AT01200642T AT01200642T ATE310078T1 AT E310078 T1 ATE310078 T1 AT E310078T1 AT 01200642 T AT01200642 T AT 01200642T AT 01200642 T AT01200642 T AT 01200642T AT E310078 T1 ATE310078 T1 AT E310078T1
Authority
AT
Austria
Prior art keywords
cav
anemia virus
chicken anemia
low pathogenicity
viruses
Prior art date
Application number
AT01200642T
Other languages
English (en)
Inventor
Carla Christina Schrier
Henricus Johannes Maria Jagt
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Application granted granted Critical
Publication of ATE310078T1 publication Critical patent/ATE310078T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/10011—Circoviridae
    • C12N2750/10021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/10011—Circoviridae
    • C12N2750/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/816—Viral vaccine for avian species, e.g. poultry or other birds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Mycology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT01200642T 2000-02-29 2001-02-22 Hühner-anäemie-virus mit geringer pathogenität ATE310078T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP00200719 2000-02-29

Publications (1)

Publication Number Publication Date
ATE310078T1 true ATE310078T1 (de) 2005-12-15

Family

ID=8171126

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01200642T ATE310078T1 (de) 2000-02-29 2001-02-22 Hühner-anäemie-virus mit geringer pathogenität

Country Status (16)

Country Link
US (3) US6723324B2 (de)
EP (1) EP1132466B1 (de)
JP (1) JP2001275664A (de)
KR (1) KR100755811B1 (de)
AT (1) ATE310078T1 (de)
AU (1) AU780550B2 (de)
BR (1) BR0100695A (de)
CA (1) CA2337618C (de)
DE (1) DE60114908T2 (de)
DK (1) DK1132466T3 (de)
ES (1) ES2252143T3 (de)
HU (1) HU225801B1 (de)
MX (1) MXPA01002167A (de)
NZ (1) NZ510130A (de)
PL (1) PL202168B1 (de)
ZA (1) ZA200101583B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001275664A (ja) * 2000-02-29 2001-10-09 Akzo Nobel Nv 低い病原性のニワトリ貧血ウイルス
US7682619B2 (en) * 2006-04-06 2010-03-23 Cornell Research Foundation, Inc. Canine influenza virus
RU2646116C1 (ru) * 2016-12-30 2018-03-01 Федеральное государственное бюджетное научное учреждение Федеральный научный центр "Всероссийский научно-исследовательский и технологический институт птицеводства" Российской академии наук Штамм вируса инфекционной анемии цыплят "ме-77" для производства инактивированных сорбированных и эмульгированных вакцин и диагностикумов
RU2659095C1 (ru) * 2017-06-14 2018-06-28 Алаутдин Серажутдинович Алиев Штамм "ИК-4" вируса инфекционной анемии цыплят

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA927014B (en) * 1991-09-20 1993-03-19 Akzo Nv Chicken anaemia agent vaccine.
GB9414888D0 (en) * 1994-07-23 1994-09-14 Univ Belfast Method and composition
WO1996040931A1 (en) * 1995-06-07 1996-12-19 Aesculaap B.V. Neutralizing conformational epitopes of chicken anemia virus
ZA978434B (en) * 1996-09-27 1998-03-26 Akzo Nobel Nv Inactivated vaccines.
JP2001275664A (ja) * 2000-02-29 2001-10-09 Akzo Nobel Nv 低い病原性のニワトリ貧血ウイルス

Also Published As

Publication number Publication date
JP2001275664A (ja) 2001-10-09
HUP0100908A3 (en) 2003-11-28
AU780550B2 (en) 2005-03-24
ES2252143T3 (es) 2006-05-16
US6723324B2 (en) 2004-04-20
HU225801B1 (en) 2007-09-28
US20010023664A1 (en) 2001-09-27
DE60114908D1 (de) 2005-12-22
AU2326201A (en) 2001-08-30
BR0100695A (pt) 2001-10-09
EP1132466B1 (de) 2005-11-16
MXPA01002167A (es) 2002-10-23
US20040156868A1 (en) 2004-08-12
PL346195A1 (en) 2001-09-10
EP1132466A1 (de) 2001-09-12
US7090854B2 (en) 2006-08-15
KR20020013361A (ko) 2002-02-20
DE60114908T2 (de) 2006-07-20
HUP0100908A2 (en) 2002-06-29
NZ510130A (en) 2002-09-27
US20040157311A1 (en) 2004-08-12
KR100755811B1 (ko) 2007-09-07
DK1132466T3 (da) 2006-01-09
ZA200101583B (en) 2001-08-31
HU0100908D0 (en) 2001-04-28
PL202168B1 (pl) 2009-06-30
US7090981B2 (en) 2006-08-15
CA2337618C (en) 2010-10-19
CA2337618A1 (en) 2001-08-29

Similar Documents

Publication Publication Date Title
DE69935721D1 (de) Kälte-adaptierte pferde influenza-viren
DK0650733T3 (da) Levende svækket in ovo-vaccine
ATE196773T1 (de) Infektiösen bronchitis virus 4/91 enthaltender geflügel-impfstoff
DE69216732D1 (de) Impfstoff gegen den Geflügelanämieerreger
NO882500L (no) Hunde-coronavirus-vaksine.
PT838222E (pt) Composicoes de vacina compreendendo imunogenios inactivados e virus da anemia dagalinha (cav) vivos
ATE310078T1 (de) Hühner-anäemie-virus mit geringer pathogenität
ES2053477T3 (es) Vacuna viva para enfermedades contagiosas de pollos.
DE68920345D1 (de) Lebendes Kombinationsvakzin.
BR0108735A (pt) Proteção in ovo contra bronquite infecciosa
DK0496135T3 (da) Cellefri Mareks sygdomsvirus-vaccine
HUP9700975A2 (hu) Élő, legyengített, Pasteurellaceae családba tartozó, RTX-termelő baktériumok
DE69228063D1 (de) Abgeschwächter rückmutierter virusimpfstoff gegen mareks krankheit serotyp-1
TH12563EX (th) วีคซีนป้องกันไวรัสโรคมาเร็คชนิดปราศจากเซลล์

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1132466

Country of ref document: EP